The Untold Stories of Breast Cancer Warriors!
In this episode of the Target Cancer Podcast, Dr. Sanjay Juneja and Douglas Feil, the Chief Program Officer for the National Breast Cancer Foundation, have a heartfelt conversation in honor of October's Breast Cancer Awareness Month. Inspired by his mother's battle with cancer, Doug shares his experiences and insights on navigating the challenges of cancer, the importance of screenings, and how to support our loved ones during their battles.
Get new episode alerts via email
Surviving Cancer. Advice from 3 Inspirational Thrivers
In the 50th podcast episode, Dr. Sanjay Janeja welcomes Kelly Thomas, Bethany Webb, and Erin Soto, who share their experiences and insights as cancer survivors and advocate for a healthy mindset during cancer treatment. In this very interesting episode, we discuss the challenges of receiving clear and accurate information about cancer diagnoses and treatments, the importance of doctor-patient communication, and the evolving landscape of cancer therapies.
Angiosarcoma survivor leads change in rare diseases
In this Target Cancer podcast episode, Dr. Corrie Painter, a survivor of angiosarcoma, shares her non-traditional journey and the challenges of a rare disease diagnosis. Her story highlights the need for greater awareness and support for rare cancers and diseases. Dr. Painter also shares some insights on the "Count Me In" initiative and how it accelerates cancer research by connecting patient data with the research community.
Does RoundUp Cause Cancer? How Carcinogens are Classified
In this episode of Target: Cancer Podcast, Dr. Sanjay Juneja and Dr. Chadi Nabhan delve into the Roundup & lymphoma connection, explore glyphosate's role, discuss oxidative stress theories, and demystify the mysteries the complexities of blood cancers. Discover factors beyond luck influencing cancer and how products that cause cancer are classified.
Get new episode alerts via email
In this informative video, Dr. Paul Kent sheds light on fibrolamellar carcinoma, a rare and often misdiagnosed liver cancer that mainly affects young adults. Understand the challenges faced by patients with fibrolamellar carcinoma and stay updated on recent successes in obtaining treatment approvals. Discover the DNAJB1-PRKACA mutation, treatment advancements, and the power of hope in facing this condition.
Breakthroughs in GI Cancer Detection: The Role of AI and Data
